Neural Progenitor Cells: Models of Toxicology for the 21st CenturyJul 28, 2016 at 12:00 PM ET
Human induced pluripotent stem cell-derived neural progenitor cells (NPCs) are an attractive in vitro model to study neurological development, neurotoxicity, and diseases of the nervous system. However, there is a lack of validated NPC lines and media that support differentiation into multiple types of neurons for disease modeling as well as drug and toxicity screening. This webinar will explore the expression of genes associated with the differentiation of NPCs during three weeks in dopaminergic differentiation media. We will then validate that ATCC NPCs and dopaminergic differentiation media are suitable for drug screening in neurotoxicity screenings in NPC-derived neurons by using a viability assay and high-content imaging analysis.
- ATCC NPCs cultured in ATCC Dopaminergic Neuron Differentiation Media express a range of specialized neural markers
- NPCs are sensitive to several compounds known for their cytotoxic effects
- The complete NPC culture system provides a validated model to investigate the neurotoxicity of a variety of chemotherapeutics
Watch The Presentation
Brian Shapiro, PhD
Scientific Content Specialist, ATCC
Brian A Shapiro, PhD, works to communicate the scientific breakthroughs of ATCC’s product development laboratories to the biomedical research community. Previously, he worked at Virginia Commonwealth University, where he investigated the role of pre-mRNA splicing in the multi-drug resistance of lung cancer. Dr. Shapiro attended the Medical College of Georgia, where his research focused on adrenal physiology as well as diseases of the epidermis.